Literature DB >> 2798781

Analyses of combined mortality data on workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Nuclear Weapons Plant.

E S Gilbert1, S A Fry, L D Wiggs, G L Voelz, D L Cragle, G R Petersen.   

Abstract

An important objective of studies of workers exposed occupationally to chronic low doses of ionizing radiation is to provide a direct assessment of health risks resulting from this exposure. This objective is most effectively accomplished by conducting combined analyses that allow evaluation of the totality of evidence from all study populations. In this paper, combined analyses of mortality in workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Nuclear Weapons Plant are presented. These combined analyses provide no evidence of a correlation between radiation exposure and mortality from all cancer or from leukemia. Of 11 other specific types of cancer analyzed, multiple myeloma was the only cancer found to exhibit a statistically significant correlation with radiation exposure. Estimates of the excess risk of all cancer and of leukemia, based on the combined data, were negative. Upper confidence limits based on the combined data were lower than for any single population, and were similar to estimates obtained from recent analyses of A-bomb survivor data. These results strengthen support for the conclusion that estimates obtained through extrapolation from high-dose data do not seriously underestimate risks of low-dose exposure, but leave open the possibility that extrapolation may overestimate risks.

Entities:  

Mesh:

Year:  1989        PMID: 2798781

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  14 in total

1.  Is it really this simple?

Authors:  Martin Charron; Brian C Lentle
Journal:  Pediatr Radiol       Date:  2003-09-16

2.  Epidemiological designs in radioepidemiological research.

Authors:  E Cardis; J Estève
Journal:  Soz Praventivmed       Date:  1991

Review 3.  Carcinogenic risk in diagnostic nuclear medicine: biological and epidemiological considerations.

Authors:  F Overbeek; E K Pauwels; J J Broerse
Journal:  Eur J Nucl Med       Date:  1994-09

4.  Cancer mortality risk among military participants of a 1958 atmospheric nuclear weapons test.

Authors:  K K Watanabe; H K Kang; N A Dalager
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

5.  Mortality among workers at a nuclear power plant in the United States.

Authors:  S Jablon; J D Boice
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

Review 6.  Histologic verification of leukemia, myelodysplasia, and multiple myeloma diagnoses in patients in Ukraine, 1987-1998.

Authors:  Irina Dyagil; Mircea Adam; Gilbert W Beebe; J David Burch; Svetlana N Gaidukova; Daniel Gluzman; Natalia Gudzenko; Victor Klimenko; LoAnn Peterson; Robert F Reiss; Stuart C Finch
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

7.  Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers.

Authors:  G M Kendall; C R Muirhead; B H MacGibbon; J A O'Hagan; A J Conquest; A A Goodill; B K Butland; T P Fell; D A Jackson; M A Webb
Journal:  BMJ       Date:  1992-01-25

8.  Occupational exposure to ionizing and non-ionizing radiation and risk of non-Hodgkin lymphoma.

Authors:  Ken K Karipidis; Geza Benke; Malcolm R Sim; Timo Kauppinen; Anne Kricker; Ann Maree Hughes; Andrew E Grulich; Claire M Vajdic; John Kaldor; Bruce Armstrong; Lin Fritschi
Journal:  Int Arch Occup Environ Health       Date:  2007-03-02       Impact factor: 2.851

Review 9.  Epidemiology of accidental radiation exposures.

Authors:  E Cardis
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

Review 10.  Cancer risk assessment of extremely low frequency electric and magnetic fields: a critical review of methodology.

Authors:  J McCann
Journal:  Environ Health Perspect       Date:  1998-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.